Results 21 to 30 of about 33,428 (239)
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
BET proteins, which influence gene expression and contribute to the development of cancer, are epigenetic interpreters. Thus, BET inhibitors represent a novel form of epigenetic anticancer treatment.
Zhi-Qiang Wang +7 more
semanticscholar +1 more source
Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation
The BET family protein BRD4, which forms the CDK9-containing BRD4-PTEFb complex, is considered to be a master regulator of RNA Polymerase II (Pol II) pause release.
B. Zheng +5 more
semanticscholar +1 more source
A Nutrient-Based Cellular Model to Characterize Acetylation-Dependent Protein-Protein Interactions
Cellular homeostasis requires the orderly expression of thousands of transcripts. Gene expression is regulated by numerous proteins that recognize post-translational modifications—in particular, the acetylation of lysine residues (Kac) on histones.
Jérémy Loehr +15 more
doaj +1 more source
Bromodomain and extraterminal (BET) proteins bind acetylated lysine residues in histones and nonhistone proteins via tandem bromodomains and regulate chromatin dynamics, cellular processes, and disease procession.
Pan Tang +4 more
semanticscholar +1 more source
The Functions of BET Proteins in Gene Transcription of Biology and Diseases
The BET (bromodomain and extra-terminal domain) family proteins, consisting of BRD2, BRD3, BRD4, and testis-specific BRDT, are widely acknowledged as major transcriptional regulators in biology.
Ka Lung Cheung +2 more
doaj +1 more source
Bromodomains as therapeutic targets [PDF]
Acetylation of lysine residues is a post-translational modification with broad relevance to cellular signalling and disease biology. Enzymes that ‘write’ (histone acetyltransferases, HATs) and ‘erase’ (histone deacetylases, HDACs) acetylation sites are an area of extensive research in current drug development, but very few potent inhibitors that ...
Muller, S, Filippakopoulos, P, Knapp, S
openaire +3 more sources
Bromodomain-containing protein 4 (BRD4) is an emerging epigenetic drug target for intractable inflammatory disorders. The lack of highly selective inhibitors among BRD4 family members has stalled the collective understanding of this critical system and ...
Zhiqing Liu +13 more
semanticscholar +1 more source
Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader
Targeted protein degradation is a powerful induced-proximity tool to control cellular concentrations of native proteins using small molecules. However, the design of selectivity in protein degradation remains challenging.
Huda, Zahid +5 more
core +1 more source
Brain vascular inflammation is characterized by endothelial activation and immune cell recruitment to the blood vessel wall, potentially causing a breach in the blood – brain barrier, brain parenchyma inflammation, and a decline of cognitive function ...
Wasiak Sylwia +14 more
doaj +1 more source
The bromodomain a chromatin browser
Reversible modification of histone tails is a regulatory step in chromatin remodeling. The N-terminal tails of histones are signaling platforms that carry amino acid residues for post-translational modification and contribute to chromosomal higher order structure. These modifications are performed by a number of chromatin modulators such as histone (h)
FILETICI P., ORNAGHI P., BALLARIO, Paola
openaire +7 more sources

